OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Bari, 1943: The Disaster That Changed Cancer Treatment

Tattoos and Cancer: Is There a Link to Skin Cancer and Lymphoma?

RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC

Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC

ESMO 2026: 5 Phase III Immunotherapy Trials to Watch

Oncology News, Insights, Stories by OncoDaily

C. S. Pramesh
Not To Miss

C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term

FDA
Gastrointestinal Oncology

FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer

Agenus
Voices

A Defining Moment for Cancer Immunotherapy During ESMO 2026 - Agenus

Arif Kamal: Excited to Join Pfizer as Chief Oncology Medical Officer

Redefining What’s Possible in MRD

“Financing WHO” – Dr. Gevorg Tamamyan Shares His Vision on How to Make WHO Foundation One of the World’s Strongest

Premenopausal HR+/HER2− Early Breast Cancer: Where Evidence Still Falls Short in Adjuvant Care

Sushil Beriwal: Faster Planning and Delivery of Breast Cancer Radiotherapy

200 Most Influential Cancer Papers Suggested by Sendurai Mani: Imatinib for CML

3D Models and Tissue Engineering for Colorectal Cancer Drug Screening

Voices
Servier Pharmaceuticals

First Patients Dosed in Servier’s Phase 2 EMBLEM-1 Cohort Evaluating Emiltatug Ledadotin for Adenoid Cystic Carcinoma

IARC and Erasmus MC Launch a New Policy Brief on Inequalities in Cancer Mortality

Abhishek Shankar: Honoured to Participate as Invited Faculty at the World Cancer Congress 2026

Meet the International Panelists at OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition

François-Xavier Danlos Answers 5 Questions on Therapeutic Cancer Vaccines - Gustave Roussy

Biagio Ricciuti and Reshma Mahtani Exchange Thoughtful Insights on ADCs at Gulf Oncology Masterclass

Building a Meaningful Career in Research Through Ophira Ginsburg’s Session - ARCCS

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

Association of Cancer Care Centers (ACCC) 43rd National Oncology Conference

Association of Cancer Care Centers

21 Oct
Association of Cancer Care Centers

Kidney Week 2026

American Society of Nephrology (ASN)

21 Oct
Kidney Week 2026

The Best of IMS Europe Webinar

International Myeloma Society (IMS)

21 Oct
IMS Asia Pacific Webinar

ESSO - Advanced Course on Breast Cancer Surgery

22 Oct
Breast Cancer Surgery

ESSO - Advanced Course on Pancreatic Cancer Surgery

European Society of Surgical Oncology

22 Oct
Pancreatic Cancer Surgery

6th European Congress on Cancer and Oncology Research - UICC

Coalesce Research Group

22 Oct
Cancer and Oncology Research

64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026)

Japan Society of Clinical Oncology

22 Oct
Japan Society of Clinical Oncology

50th International Conference on Screening for Lung Cancer and 18th Conference on Research for Early Lung Cancer Treatment

International Early Lung Cancer Action Program

22 Oct
Lung Cancer

The WVOS 2026 Fall Conference

West Virginia Oncology Society

22 Oct
WVOS 2026

ESSO – Technical Aspects of Lymph Node Dissection in Gastric Cancer Surgery

European Society of Surgical Oncology

22 Oct
Surgical Anatomy Course

The 37th Annual Fall Foliage Cancer Conference

Continuing Cancer Education, Inc

23 Oct
Fall Foliage Cancer

Immune-oncology
ESMO 2026: 5 Phase III Immunotherapy Trials to Watch

ESMO 2026: 5 Phase III Immunotherapy Trials to Watch

ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC?

Can Live Tumor Biopsies Predict Immunotherapy Response?

KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC

DECIDE-MET Trial: Targeted Therapy or Immunotherapy First in METex14 NSCLC?

Gastrointestinal-Oncology
FDA

FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer

10 Must-Read Posts In GI Oncology This Week

3D Models and Tissue Engineering for Colorectal Cancer Drug Screening

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma

Phase 3b SIERRA: Durvalumab Plus Tremelimumab in Poor-Prognosis Unresectable HCC

Breast-Oncology
Breast cancer in Algeria

Breast Cancer in Algeria in 2026: Can Access Keep Up With Therapeutic Progress?

Beyond CDK4/6: Next-Generation CDK Inhibitors Aim to Overcome Resistance in HR+/HER2− Breast Cancer

Premenopausal HR+/HER2− Early Breast Cancer: Where Evidence Still Falls Short in Adjuvant Care

ESMO 2026: 10 Breast Cancer ADCs to Watch in Madrid

HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC

ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes

MAMMÔ 2026: Precision, De-Escalation and New Treatment Sequencing Reshape Breast Cancer Care

Lung-Oncology
RASolve 308

RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC

Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease

ESMO 2026: 10 ADCs in Lung Cancer to Watch

FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC

LIGHT-NING: Real-World Nivolumab Plus Ipilimumab Shows Durable Outcomes in Metastatic NSCLC

Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

OncoDaily TV
Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

Not To Miss
C. S. Pramesh

C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term

Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC

ESMO Congress 2028 Heads to Milan: An International Gathering for Cancer Research and Care

20 Posts Not To Miss From ASCOQLTY26

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Breast Health Day 2026: Why Early Detection Matters and Why Screening Cannot Wait

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy

OncoGrants
Veteran Cancer

Conquer Cancer YIA for Veteran Cancer 2027

John Robert Lewis

AACR-Lustgarten Foundation Career Development Award for Pancreatic Cancer Research - in Honor of John Robert Lewis 2027

Allied World–St. Baldrick’s Survivorship

Allied World–St. Baldrick’s Survivorship and Supportive Care Research Grant 2027

AACR–QuadW

AACR–QuadW Foundation Sarcoma Research Fellowship 2027

Survivorship Research

Conquer Cancer YIA in Survivorship Research 2027

Laboratory Integration Program

CRI Clinic and Laboratory Integration Program 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Matheus de Oliveira Andrade

Matheus de Oliveira Andrade

Oncologists Location Brasília, Brazil
Hesham ElGhazaly

Hesham ElGhazaly

Oncologists Location Cairo, Egypt
Allison F. O'Neill

Allison F. O’Neill

Oncologists Location Boston, USA
Sara Tolaney

Sara Tolaney

Oncologists Location Boston, USA
Shubha De Sarkar

Shubha De Sarkar

Oncologists Location Jaipur, India
Eduard-Alexandru Bonci

Eduard-Alexandru Bonci

Oncologists Location Lisbon, Portugal
Emad Shash

Emad Shash

Oncologists Location Cairo, Egypt
Naveen Kumar

Naveen Kumar

Oncologists Location Thiruvananthapuram, India

Drugs Atlas
Imatinib (Gleevec): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in CML, GIST, and Other KIT/PDGFR-Driven Malignancies Imatinib (Gleevec) Oct 20, 2026 1:36 am
Lenvatinib (Lenvima): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Thyroid Cancer, RCC, HCC, and Endometrial Cancer Lenvatinib (Lenvima) Oct 18, 2026 2:06 pm
Regorafenib (Stivarga): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Colorectal Cancer, GIST, and Hepatocellular Carcinoma Regorafenib (Stivarga) Oct 18, 2026 2:05 pm
Sorafenib (Nexavar): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HCC, RCC, and Differentiated Thyroid Cancer Sorafenib (Nexavar) Oct 18, 2026 2:14 am
Pazopanib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Renal Cell Carcinoma and Soft Tissue Sarcoma Pazopanib Oct 18, 2026 2:13 am
Axitinib (Inlyta): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Advanced Renal Cell Carcinoma Axitinib (Inlyta) Oct 18, 2026 2:10 am
Cabozantinib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in RCC, HCC, Thyroid Cancer, and Neuroendocrine Tumors Cabozantinib Oct 18, 2026 2:09 am
Tucatinib (Tukysa): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HER2-Positive Breast Cancer and Colorectal Cancer Tucatinib (Tukysa) Oct 15, 2026 1:47 pm
Sunitinib (Sutent): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in RCC, GIST, and Pancreatic Neuroendocrine Tumors Sunitinib (Sutent) Oct 15, 2026 1:45 pm
Lapatinib (Tykerb): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HER2-Positive Breast Cancer Lapatinib (Tykerb) Oct 14, 2026 4:57 am

OncoDaily Magazine

New Paper Alert
Stephen Liu

Stephen Liu on the AMAZE-lung Trial of Amivantamab, Lazertinib, and Bevacizumab in EGFR-Mutant NSCLC

Michael Dickinson, Lymphoma Symposium

Michael Dickinson Highlights Outcomes and CNS Relapse Patterns in High-Grade B-Cell Lymphoma

Eduardo Bruera

Eduardo Bruera Highlights Selective Use of Urine Drug Testing in Cancer Pain Clinics

Wafik S. El-Deiry

Wafik El-Deiry: Unraveling Cancer Plasticity and Histological Transformation in Precision Oncology

Lucia Santorelli

Lucia Santorelli: Landmark Study Uncovers Placental-Like Reprogramming in Early-Onset Colorectal Cancer

Sia Daneshmand

Sia Daneshmand: Combining Treatments to Improve Durable Responses in Non-Muscle-Invasive Bladder Cancer

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts